COMP <GO>
NVST vs MRK // FREE CASH FLOW YIELD
Envista Holdings Corporation (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: NVST 4
— MRK 11
▲ FREE CASH FLOW YIELD LEADER: NVST
LAST: $23.51 (-4.47%) • MKT CAP: $3.95B
fcf-yield
5.83%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
fcf-yield
3.42%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NVST VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NVST | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 54.70% | 74.80% | -20.10 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.10% | 20.70% | -15.60 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.5x | 15.3x | +1.20 | MRK | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 5.83% | 3.42% | +2.41 | NVST | /fcf-yield <GO> |
| Operating Margin | 7.90% | 34.30% | -26.40 | MRK | /operating-margins <GO> |
| Net Profit Margin | 1.70% | 28.10% | -26.40 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 8.30% | 1.30% | +7.00 | NVST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.61 | 5.19 | -3.58 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | NVST | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.60% | +0.10 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.7 | 56.9 | -9.20 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 0.92 | +0.01 | NVST | /macro-sensitivity <GO> |
| Forward P/E Multiple | 78.2x | 18.4x | +59.80 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.95B | $361.02B | -$357.07B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NVST REV | MRK REV | NVST GROSS % | MRK GROSS % | NVST FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.72B | $65.01B | 54.7% | 74.8% | $230.4M | $12.36B |
| FY 2024 | $2.51B | $64.17B | 54.7% | 76.3% | $302.7M | $18.10B |
| FY 2023 | $2.57B | $60.12B | 44.0% | 44.0% | $160.2M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NVST // BETA 0.93
MRK // BETA 0.92